Home | Welcome to Contract Pharma   
Last Updated Monday, September 1 2014
Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published January 7, 2011
Effie Toshav, J.D., has been appointed senior vice president and general counsel at AVI BioPharma, effective January 10th. Read More »
Published March 18, 2008
Gary M. Clark, Ph.D., has joined Array BioPharma, Inc. as vice president of biostatistics and data management. Dr. Clark will oversee the company's biostatistics and data management activities on its growing pipeline of targeted small molecule drugs… Read More »
Published September 26, 2007
Baxter BioPharma Solutions recently completed the lyophilization capacity expansion at their cytotoxic contract manufacturing facility in Halle, Germany. The expansion increased their total cytotoxic lyophilization capacity to four dedicated lyophili… Read More »
Published August 29, 2007
PDL BioPharma, Inc., following a business and portfolio review, has changed its strategic focus to the discovery and development of novel antibodies in oncology and select immunological diseases. According to a company statement, it will realign its… Read More »
Published July 7, 2006
PDL BioPharma, Inc. plans to move its corporate headquarters from Fremont to Redwood City, CA during the third quarter of 2007. PDL has signed long-term leases for two existing buildings that total approximately 450,000 sq.-ft. The new headquarters w… Read More »
Published April 17, 2006
Sentry Logistic Solutions launched its services and the opening of its $8 million, 53,000-sq.-ft. facility designed for cold chain logistics, storage and packing of bulk pharmaceutical and biotechnology components and finished products. "Se… Read More »
Published April 11, 2006
Array BioPharma and AstraZeneca have selected a third compound for their small molecule MEK anti-cancer program, triggering a $1 million milestone payment by AstraZeneca. The second compound was selected in January 2006, also triggering a $1 million… Read More »
Published June 3, 2014
U.S. biopharma has a good image, according to APCO’s latest study, but proactive attention to policymakers and healthcare providers may be helpful Read More »
Will Cell-Based Therapy Shape Biopharma’s Future?
Published June 3, 2014
Pluristem’s CEO, Zami Aberman, compares the state of stem cell research today to where antibodies were 20 years ago. Clinical evidence is key to moving the technology forward, he says. Read More »
ARL BioPharma, Inc.
By Greg Thomas, VP Business Development
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On